We further evaluated the correlation between β-catenin and NE in ovarian benign tumors or ovarian serous cancer separately and the results showed that NE expression was significantly related to β-catenin expression in both benign (Fig. 6i) and malignant (Fig. 6j) ovarian tumors. Here, ELANE is linked to ovarian serous adenocarcinoma.